30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Helen Thackray

Track

Insider profile

Currently holds positions in BioCryst Pharmaceuticals Inc and Crescent Biopharma Inc

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 89% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director BioCryst Pharmaceuticals Inc Sept. 20, 2019 -
Senior Vice President - Clinical Development, Chief Medical Officer Crescent Biopharma Inc Jan. 1, 2017 -
Vice President - Clinical Development, Chief Medical Officer Crescent Biopharma Inc Jan. 1, 2012 - Jan. 1, 2017
Vice President - Clinical Development Crescent Biopharma Inc Jan. 1, 2006 - Jan. 1, 2012
Helen Thackray's trades of BioCryst Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-25 2025-11-25
PrS Proposed sale
6,723
15.29
US$3,902,766 		6,723 15.29 US$3,902,766
2025-11-21 2025-11-21
PrS Proposed sale
20,402
141.80
US$2,515,375 		20,402 141.80 US$2,515,375
2024-05-15 2024-05-14
B Purchase
78,876 -34.6%
356.42
US$4,475,893 		78,876 -34.6% 356.42 US$4,475,893
2023-04-05 2023-04-03
PlS Planned sale
7,000 -3.3%
8.29
US$58,030 		7,000 -3.3% 8.29 US$58,030
2022-12-19 2022-12-15
PlS Planned sale
3,125 -2.3%
10.89
US$34,031 		3,125 -2.3% 10.89 US$34,031
2022-04-04 2022-04-01
PlS Planned sale
7,600 -5.3%
16.20
US$123,120 		7,600 -5.3% 16.20 US$123,120
2017-12-12 2017-12-08
S Sale
2,000 -1.3%
15.01
US$30,020 		2,000 -1.3% 15.01 US$30,020
2017-09-18 2017-09-18
S Sale
2,000 -1.3%
13.00
US$26,000 		2,000 -1.3% 13.00 US$26,000
2017-05-30 2017-05-25
S Sale
2,000 -1.3%
15.57
US$31,140 		2,000 -1.3% 15.57 US$31,140
2017-05-22 2017-05-19
PlS Planned sale
2,000 -1.3%
12.14
US$24,280 		2,000 -1.3% 12.14 US$24,280
2016-10-04 2016-10-03
PlS Planned sale
100 -0.1%
7.01
US$701 		100 -0.1% 7.01 US$701
2016-10-04 2016-10-03
PlS Planned sale
3,900 -2.4%
7.00
US$27,300 		3,900 -2.4% 7.00 US$27,300
2016-07-21 2016-07-20
PlS Planned sale
2,000 -1.2%
8.00
US$16,000 		2,000 -1.2% 8.00 US$16,000
2016-07-06 2016-07-06
PlS Planned sale
6,796 -4.0%
6.68
US$45,397 		6,796 -4.0% 6.68 US$45,397
2016-07-06 2016-07-05
PlS Planned sale
10,136 -5.6%
7.01
US$71,053 		10,136 -5.6% 7.01 US$71,053
2016-07-06 2016-07-01
PlS Planned sale
5,068 -2.7%
7.40
US$37,503 		5,068 -2.7% 7.40 US$37,503